Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
US9012408B2 · kind B2 · utility
4Cited by
24References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2013 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Jul 13, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.